Evaluation of the biodistribution and radiation dosimetry of the 18F-labelled amyloid imaging probe [18F]FACT in humans

EJNMMI Research

Volumn 3, Issue 1, 2013, Pages 1-10

  Shidahara, Miho ^a,b   Tashiro, Manabu ^b   Okamura, Nobuyuki ^a   Furumoto, Shozo ^a   Furukawa, Katsutoshi ^b   Watanuki, Shoichi ^b   Hiraoka, Kotaro ^b   Miyake, Masayasu ^b   Iwata, Ren ^b   Tamura, Hajime ^a   Arai, Hiroyuki ^b   Kudo, Yukitsuka ^c   Yanai, Kazuhiko ^a,b  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Amyloid imaging; MIRD; Positron emission tomography; Radiation dosimetry

Indexed keywords

AMYLOID; FLUORINE 18;

AGED; ANATOMICAL VARIATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOSIMETRY; DRUG ABSORPTION; DRUG DETERMINATION; DRUG STRUCTURE; FEMALE; GALLBLADDER; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IMAGE DISPLAY; LARGE INTESTINE; LIVER; MALE; MOLECULAR IMAGING; MOUSE; NONHUMAN; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; SMALL INTESTINE;

EID: 84878798866     PISSN: None     EISSN: 2191219X     Source Type: Journal    
DOI: 10.1186/2191-219X-3-32     Document Type: Article

References (22)

1. Hardy J, Selkoe DJ: The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
2. Furumoto S, Okamura N, Iwata R, Yanai K, Arai H, Kudo Y: Recent advances in the development of amyloid imaging agents. Curr Top Med Chem 2007, 7:1773-1789.
3. Kudo Y, Okamura N, Furumoto S, Tashiro M, Furukawa K, Maruyama M, Itoh M, Iwata R, Yanai K, Arai H: 2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6-(2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients. J Nucl Med 2007, 48:553-561.
4. 11C]CHIBA-1001 in humans. Nucl Med Biol 2011, 38:443-448.
5. Deloar HM, Fujiwara T, Shidahara M, Nakamura T, Watabe H, Narita Y, Itoh M, Miyake M, Watanuki S: Estimation of absorbed dose for 2-[F-18]fluoro-2-deoxy-D-glucose using whole-body positron emission tomography and magnetic resonance imaging. Eur J Nucl Med Mol Imaging 1998, 25:565-574.
6. Sakata M, Oda K, Toyohara J, Ishii K, Nariai T, Ishiwata K: Direct comparison of radiation dosimetry of six PET tracers using human whole-body imaging and murine biodistribution studies. Ann Nucl Med 2013, 27:285-296.
7. 11C-PIB in humans. J Nucl Med 2007, 48:128-133.
8. 18F]AV-45, a novel amyloid imaging agent-a pilot study. Nucl Med Biol 2010, 37:497-508.
9. 18F-AV-45 (florbetapir [corrected] F 18). J Nucl Med 2010, 51:913-920.
10. 18F-GE067: a radioligand for in vivo brain amyloid imaging. J Nucl Med 2009, 50:818-822.
11. 18F-BAY94-9172. J Nucl Med 2009, 50:309-315.
12. 18F-labeled BF-227 derivative as a potential radioligand for imaging dense amyloid plaques by positron emission tomography. Mol Img Biol. in press.
13. Fujiwara T, Watanuki S, Yamamoto S, Miyake M, Seo S, Itoh M, Ishii K, Orihara H, Fukuda H, Satoh T, Kitamura K, Tanaka K, Takahashi S: Performance evaluation of a large axial field-of-view PET scanner: SET-2400W. Ann Nucl Med 1997, 11:307-313.
14. Watanuki S, Tashiro M, Miyake M, Ishikawa Y, Itoh M, Yanai K, Sakemi Y, Fukuda H, Ishii K: Long-term performance evaluation of positron emission tomography: analysis and proposal of a maintenance protocol for longterm utilization. Ann Nucl Med 2010, 24:461-468.
15. Loevinger R, Budinger T, Watson E: MIRD Primer for Absorbed Dose Calculations. Revised edn. New York: The Society of Nuclear Medicine; 1991.
16. Cristy M, Eckerman KF: Specific Absorbed Fractions of Energy at Various Ages from Internal Photon ources. Oak Ridge: ORNL/TM; 1987:8381.
17. Stabin MG, Sparks RB, Crowe E: OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 2005, 46:1023-1027.
18. 131I-19-iodocholesterol: the pitfalls of using tissue concentration data-reply. J Nucl Med 1975, 16:248-249.
19. Lartizien C, Comtat C, Kinahan PE, Ferreira N, Bendriem B, Trebossen R: Optimization of injected dose based on noise equivalent count rates for 2-and 3-dimensional whole-body PET. J Nucl Med 2002, 43:1268-1278.
20. ICRP: Radiological Protection in Biomedical Research. Oxford: Pergamon; 1992.
21. 18F-SP203, to image metabotropic glutamate subtype 5 receptors in humans. Eur J Nucl Med Mol Imaging 2010, 37:1943-1949.
22. Directorate-General Environment NSaCP: Guidance on medical exposures in medical and biomedical research. In Radiation Protection. Brussels: European Commission; 1998:1-14.